Go offline with the Player FM app!
Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly]
Manage episode 433875456 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.
Up this week:
The good — Amneal gets FDA nod for Parkinson’s pill
The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure
The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy
64 episodes
Manage episode 433875456 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.
Up this week:
The good — Amneal gets FDA nod for Parkinson’s pill
The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure
The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy
64 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.